Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

17.43 -0.65 (-3.60%)

Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	972,548
Open	17.96
Bid (Size)	17.39 (500)
Ask (Size)	17.44 (700)
Prev. Close	18.08
Today's Range	17.07 - 18.04
52wk Range	8.800 - 32.71
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BBNX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. and Encourages Investors to Contact the Firm

Today 15:32 EDT

From Bragar Eagel & Squire

Via GlobeNewswire

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

Today 10:03 EDT

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Performance

52-Week Range 46.7% below 52-week high

17.43

8.8052W Low 32.7152W High

1 Week 10.3% below 1-week high

17.931W Low 19.441W High

Beta Bionics, Inc. - Common Stock (BBNX) traded between $8.80 and $32.71 over the past 52 weeks and last traded at $17.43, 46.7% below its 52-week high. Over the past week it ranged between $17.93 and $19.44.

Past 12 Months

-7.6%

-9.8%

+7.7%

+78.0%

-40.4%

-21.3%

1W -$1.44

1M -$1.90

3M +$1.25

6M +$7.64

YTD -$11.82

1Y -$4.72

BBNX was -21.3% over the past year, +78.0% over six months, -40.4% year to date, -7.6% in the last week.

12 Months vs Market

BBNX

-21.3%

DIA

+9.8%

SPY

+15.7%

QQQ

+23.7%

IWM

+13.7%

Over the past 12 months BBNX returned -21.3% versus DIA (Dow) +9.8%, SPY (S&P 500) +15.7%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 0.73× 3-mo avg

Today 972,548 3-mo avg 1.3M

946.4K

1.5M

1.3M

1.2M

YTD

1.2M

1.1M

BBNX most recently traded 972,548 shares against a 3-month average daily volume of 1.3M.

More News

Kirby McInerney LLP Alerts Investors Who Acquired Beta Bionics, Inc. BBNX Securities Between July 30, 2025 and February 24, 2026 of Pending Lawsuit

Today 10:00 EDT

From Kirby McInerney LLP

Via Business Wire

Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Beta Bionics, Inc. (NASDAQ: BBNX) on November 3, 2026

Today 8:15 EDT

Via NewMediaWire

Kaplan Fox Reminds Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) - Deadline is November 3, 2026

October 07, 2026

Via NewMediaWire

BBNX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

October 07, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Kaplan Fox Reminds Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Securities Class Action Deadline – Contact the Firm Before November 3, 2026

October 07, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

October 06, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Deadline on November 3, 2026 for a Leadership Role

October 06, 2026

Via NewMediaWire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX

October 06, 2026

From Pomerantz LLP

Via GlobeNewswire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

October 06, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Kaplan Fox Advises Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Act Before the Lead Plaintiff Deadline on November 3, 2026

October 06, 2026

Via NewMediaWire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. (BBNX)

October 06, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Kaplan Fox Announces a Securities Class Action Filed Against Beta Bionics, Inc. (NASDAQ: BBNX) - Lead Plaintiff Deadline is November 3, 2026

October 05, 2026

Via NewMediaWire

NASDAQ: BBNX INVESTOR ALERT: Berger Montague Advises Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a November 3, 2026 Deadline

October 05, 2026

From Berger Montague

Via GlobeNewswire

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

October 05, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

BBNX Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Lawsuit Against Beta Bionics, Inc.

October 05, 2026

Via Newsfile

Kaplan Fox Alerts Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) – Deadline is November 3, 2026

October 05, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

October 03, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Kaplan Fox Alerts Investors of Beta Bionics, Inc. (NASDAQ: BBNX) With Significant Losses to a Securities Class Action Deadline on November 3, 2026

October 02, 2026

Via NewMediaWire

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 3, 2026 in Beta Bionics, Inc. Lawsuit - BBNX

October 02, 2026

From Levi & Korsinsky, LLP

Via ACCESS Newswire

BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit

October 02, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of an Upcoming Lead Plaintiff Deadline on November 3, 2026

October 02, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors Who Suffered Losses to a Securities Class Action - Deadline is November 3, 2026

October 01, 2026

Via NewMediaWire

Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors With Significant Losses to Seek a Leadership Role Before Deadline on November 3, 2026

October 01, 2026

Via NewMediaWire

Frequently Asked Questions

Is Beta Bionics, Inc. - Common Stock publicly traded?

Yes, Beta Bionics, Inc. - Common Stock is publicly traded.

What exchange does Beta Bionics, Inc. - Common Stock trade on?

Beta Bionics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Beta Bionics, Inc. - Common Stock?

The ticker symbol for Beta Bionics, Inc. - Common Stock is BBNX on the Nasdaq Stock Market

What is the current price of Beta Bionics, Inc. - Common Stock?

The current price of Beta Bionics, Inc. - Common Stock is 17.43

When was Beta Bionics, Inc. - Common Stock last traded?

The last trade of Beta Bionics, Inc. - Common Stock was at 10/08/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.